semaglutide nash and MASH resolution: A pooled analysis of recent trials - Abouelmagd - 2025 - Diabetes, Obesity and Metabolism Reproducible efficacy and clinical translatability

Months 6 to 12: Patients in the CONQUER and EQUIP trials reached peak results around week 56

Disclaimer: While we work to ensure that product information is correct, on occasion manufacturers may alter their ingredient lists

It manages collagen production, leading to firmer, smoother skin

BEST BY DATE 11/30/2024

Clinical Topics: Arrhythmias and Clinical EP, COVID-19 Hub, Heart Failure and Cardiomyopathies, Noninvasive Imaging, Atrial Fibrillation/Supraventricular Arrhythmias, Acute Heart Failure, Echocardiography/Ultrasound Keywords: ESC Congress, ESC24, Diabetes Mellitus, Type 2, Atrial Fibrillation, Heart Failure, COVID-19, Obesity, Echocardiography